COVID-19: Speaking at a distance of 50 cm: High risk even with a mask on:
Category: medical service
COVID-19: Corona drug’S-217622′ clinical trial result: Shionogi Pharmaceutical
COVID-19: Canada fails to develop vaccine with Cansino:
COVID-19: Chinese inactivated vaccine, less effective against Omicron strains: Nature
COVID-19: “5-ALA” is also effective for mutant strains: Nagasaki University announced